12:00 AM
Apr 03, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

EHT899: Phase I

ENZ said its 15-patient Phase I trial in Israel showed improvement in disease symptoms in a majority of patients, including a decrease...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >